Author:
Kirubarajan Abirami,Lynch Meghan,Nasreen Sharifa,Gebretekle Gebremedhin B.,Fadel Shaza A.,Crowcroft Natasha S.,Allin Sara
Abstract
Abstract
Background
There is low uptake of the pneumococcal vaccination in eligible older adults, even in high-income countries that offer routine and universal vaccination programs.
Objective
To systematically characterize interventions aimed at improving pneumococcal vaccine uptake in older adults.
Design
We conducted a scoping review following PRISMA-SCr guidelines of five interdisciplinary databases: Medline-Ovid, Embase, CINAHL, PsychInfo, and Cochrane Library. Databases were searched from January 2015 until April 2020. The interventions were summarized into three pillars according to the European Union Conceptional Framework for Action: information campaigns, prioritization of vaccination schemes, and primary care interventions.
Results
Our scoping review included 39 studies that summarized interventions related to pneumococcal vaccine uptake for older adults, encompassing 2,481,887 study participants (945 healthcare providers and 2,480,942 older adults) across seven countries. Examples of interventions that were associated with increased pneumococcal vaccination rate included periodic health examinations, reminders and decision-making tools built into electronic medical records, inpatient vaccination protocols, preventative health checklists, and multimodal educational interventions. When comparing the three pillars, prioiritization of vaccination schemes had the highest evidence for improved rates of vaccination (n = 14 studies), followed by primary care interventions (n = 8 studies), then information campaigns (n = 5 studies).
Conclusion
Several promising interventions were associated with improved outcomes related to vaccine uptake, although controlled study designs are needed to determine which interventions are most effective.
Publisher
Springer Science and Business Media LLC
Subject
Geriatrics and Gerontology
Reference81 articles.
1. Sims RV, Steinmann WC, McConville JH, King LR, Zwick WC, Schwartz JS. The clinical effectiveness of pneumococcal vaccine in the elderly. Ann Intern Med. 1988;108(5):653–7.
2. Fedson DS, Henrichsen J, Mäkelä PH, Austrian R. Immunization of elderly people with polyvalent pneumococcal vaccine. Infection. 1989 Nov;17(6):437–41.
3. Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. Jama. 1993;270(15):1826–31.
4. Drijkoningen JJ, Rohde GG. Pneumococcal infection in adults: burden of disease. Clin Microbiol Infect. 2014 May;20:45–51.
5. Centers for Disease Control and Prevention (CDC). Influenza and pneumococcal vaccination coverage among persons aged > or = 65 years–United States, 2004–2005. MMWR Morbidity and mortality weekly report. 2006;55(39):1065–8.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献